Biogennix is a trailblazing company in the field of advanced osteobiologic products for bone graft procedures. Established in 2009, the company is headquartered in Irvine, California, at the heart of Southern California’s “Technology Coast.” With a focus on Biotechnology, Health Care, and Manufacturing industries, Biogennix's commitment to providing innovative bone grafting solutions is underscored by its team of expert scientists and management. The company's track record in bone regeneration and the medical device sector has been lauded for delivering cutting-edge results. However, information regarding the latest investment and investors is currently unavailable. For further details, interested parties are encouraged to visit Biogennix's website at www.Biogennix.com.
There is no investment information
No recent news or press coverage available for Biogennix.